story of the week
Sodium Phenylbutyrate–Taurursodiol for ALS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
N. Engl. J. Med 2020 Sep 03;383(10)919-930, S Paganoni, EA Macklin, S Hendrix, JD Berry, MA Elliott, S Maiser, C Karam, JB Caress, MA Owegi, A Quick, J Wymer, SA Goutman, D Heitzman, T Heiman-Patterson, CE Jackson, C Quinn, JD Rothstein, EJ Kasarskis, J Katz, L Jenkins, S Ladha, TM Miller, SN Scelsa, TH Vu, CN Fournier, JD Glass, KM Johnson, A Swenson, NA Goyal, GL Pattee, PL Andres, S Babu, M Chase, D Dagostino, SP Dickson, N Ellison, M Hall, K Hendrix, G Kittle, M McGovern, J Ostrow, L Pothier, R Randall, JM Shefner, AV Sherman, E Tustison, P Vigneswaran, J Walker, H Yu, J Chan, J Wittes, J Cohen, J Klee, K Leslie, RE Tanzi, W Gilbert, PD Yeramian, D Schoenfeld, ME CudkowiczFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.